Multidisciplinary non-drug program to improve quality of life after solid organ transplant
Official title: Integrated Multidisciplinary Non-Pharmacological Treatment for Improving Health-Related Quality of Life in Solid Organ Transplant Recipients: A Randomized Single-Center Pilot Study
Run by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · NCT07870811 · Data updated 2026-11-12
A multidisciplinary, non-drug program using acupuncture, remote physical rehab, and brain-health activities is being tested to see if it can improve quality of life for adults at least one year after heart, kidney, liver, or lung transplant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | The Mediterranean Institute for Transplantation and Advanced Specialized Therapies Academic / other |
| Locations | 1 site (Palermo, Palermo) |
| Status | Recruiting |
| Started | April 27, 2026 |
| Main results expected | October 21, 2026 |
| Study ends | October 21, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07870811 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 25–65 who had a liver, kidney, heart, or lung transplant at least 1 year ago and who meet specific QoL criteria.
✕Probably not a fit
Patients with significant cognitive impairment, active graft rejection, or contraindications to exercise may not benefit or participate.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center study tests a non-pharmacological approach for solid organ transplant recipients. The program combines acupuncture, telerehabilitation-based physical therapy, and psychological/brain-health support to see if health-related quality of life and well-being can be improved. Eligibility includes adults 25–65 who are at least one year post-transplant with certain quality-of-life indicators and no contraindications to exercise. The trial will provide preliminary estimates of impact and assess feasibility of implementing this approach in clinical practice.
Why it matters
Potential benefit: If successful, participants may experience improved quality of life and well-being after transplantation.
How similar studies have gone: Previous research in non-pharmacological support for transplant recipients suggests potential QoL benefits but this specific multidisciplinary combination is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 25 years and ≤ 65 years; * Solid organ transplantation (liver, kidney, heart, or lung) performed at least 1 year prior to enrollment, with good graft functional recovery according to organ-specific criteria; * Ability to understand and independently complete questionnaires; * Ability to provide written informed consent; * Absence of clinical contraindications to therapeutic exercise; * Adequate cognitive status; * SF-36 score \< 50 or Distress Thermometer (DT) score ≥ 4 and Pittsburgh Sleep Quality Index (PSQI) score ≥ 5. Exclusion Criteria: * Diagnosis of severe cognitive impairment, acute psychiatric illness, or significant hearing or visual disability; * Severe ongoing complications or comorbidities that would prevent participation in the physiotherapy program; * Unstable immunosuppressive therapy and/or evidence of ongoing graft rejection; * Diagnosis of active malignancy; * Pregnancy.
Where it's running
-
IRCCS ISMETT - Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione
Palermo, Palermo, Italy Recruiting
Study contacts
- Study coordinator: Giada Pietrosi
- Email: gpietrosi@ismett.edu
- Phone: +39 0912192111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Research on improving outcomes for lung transplant donors and recipients
This study is trying to see how different donor and medical practices affect the health of lung transplant patients and donors, while also looking for blood markers that might predict complications after the surgery.
-
Multimodal prospective approach to understand acute and chronic lung transplant rejection
This project will see if blood tests, airway sampling, imaging, and genetic analyses can identify which adults who have had or are being evaluated for a lung transplant will develop antibody‑mediated rejection and later chronic graft dysfunction.
-
Airway response to exercise after double lung transplant
This study will see if short (5-minute) versus longer (15-minute) constant-work exercise causes different airway narrowing and breathlessness in people who have had a double lung transplant.
-
Measuring breathing effort before and after removing the breathing tube
This will test a new electrical impedance method to measure breathing effort in adults on ventilators as they try breathing on their own and after the breathing tube is removed.
-
Cryo nerve block to improve recovery after bilateral lung transplant
This pilot will test whether adding a cryo nerve block around the chest helps people with end-stage COPD recover better after a bilateral lung transplant.
-
Identifying noninvasive markers of heart transplant rejection in patients with congenital heart disease
This study is testing a new blood test to see if it can help detect heart transplant rejection in patients with congenital heart disease without needing a more invasive procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.